Zydus Cadila gets final USFDA nod for Macitentan Tablets and eligibility for 180-day shared exclusivity Read more
Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat relapsed or refractory multiple myeloma Read more